Molecular Dissection of the 5q Deletion in Myelodysplastic Syndrome

Seminars in Oncology

Volumn 38, Issue 5, 2011, Pages 621-626

  Ebert, Benjamin L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; MEMBRANE PROTEIN; MICRORNA; MICRORNA 145; MICRORNA 146A; NUCLEOPHOSMIN; PROTEIN DIAPH1; PROTEIN P53; PROTEIN RPS14; UNCLASSIFIED DRUG;

5Q- SYNDROME; ANEMIA; ARTICLE; CHROMOSOME 5Q; CHROMOSOME DELETION 5; DISEASE ASSOCIATION; DISEASE COURSE; ERYTHROID CELL; GENE EXPRESSION; GENE SEQUENCE; GENOTYPE PHENOTYPE CORRELATION; HAPLOINSUFFICIENCY; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; MACROCYTIC ANEMIA; MEGAKARYOCYTE; MYELODYSPLASTIC SYNDROME; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; THROMBOCYTE; TRANSFUSION;

ANEMIA, MACROCYTIC; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 5; DISEASE PROGRESSION; HAPLOINSUFFICIENCY; HUMANS; MYELODYSPLASTIC SYNDROMES; PHENOTYPE;

EID: 80053198659     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2011.04.010     Document Type: Article

References (48)

1. A.A. Giagounidis, U. Germing, and C. Aul Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies Clin Cancer Res 12 2006 5 10 (Pubitemid 43166169)
2. A.A. Giagounidis, U. Germing, J.S. Wainscoat, J. Boultwood, and C. Aul The 5q-syndrome Hematology 9 2004 271 277 (Pubitemid 39359347)
3. L. Teerenhovi Specificity of haematological indicators for '5q-syndrome' in patients with myelodysplastic syndromes Eur J Haematol 39 1987 326 330 (Pubitemid 18067850)
4. H. Van den Berghe, and L. Michaux 5q-, twenty-five years later: a synopsis Cancer Genet Cytogenet 94 1997 1 7 (Pubitemid 27133494)
5. H. Van den Berghe, J.J. Cassiman, G. David, J.P. Fryns, J.L. Michaux, and G. Sokal Distinct haematological disorder with deletion of long arm of no. 5 chromosome Nature 251 1974 437 438
6. H. Van den Berghe, K. Vermaelen, C. Mecucci, D. Barbieri, and G. Tricot The 5q-anomaly Cancer Genet Cytogenet 17 1985 189 255
7. B.L. Ebert Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer Leukemia 23 2009 1252 1256
8. J. Boultwood, C. Fidler, and S. Lewis Molecular mapping of uncharacteristically small 5q deletions in two patients with the 5q-syndrome: delineation of the critical region on 5q and identification of a 5q- breakpoint Genomics 19 1994 425 432 (Pubitemid 24071315)
9. J. Boultwood, C. Fidler, and A.J. Strickson Narrowing and genomic annotation of the commonly deleted region of the 5q-syndrome Blood 99 2002 4638 4641 (Pubitemid 34627240)
10. J. Fairman, I. Chumakov, A.C. Chinault, P.C. Nowell, and L. Nagarajan Physical mapping of the minimal region of loss in 5q- chromosome Proc Natl Acad Sci U S A 92 1995 7406 7410
11. F. Lai, L.A. Godley, and J. Joslin Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q) Genomics 71 2001 235 245 (Pubitemid 32165090)
12. N. Zhao, A. Stoffel, and P.W. Wang Molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases to 1-1.5 Mb and preparation of a PAC-based physical map Proc Natl Acad Sci U S A 94 1997 6948 6953 (Pubitemid 27281971)
13. A.A. Giagounidis, and C. Aul The 5q-syndrome Cancer Treat Res 142 2008 133 148
14. P. Mathew, A. Tefferi, and G.W. Dewald The 5q-syndrome: a single-institution study of 43 consecutive patients Blood 81 1993 1040 1045 (Pubitemid 23054843)
15. S.D. Nimer Clinical management of myelodysplastic syndromes with interstitial deletion of chromosome 5q J Clin Oncol 24 2006 2576 2582 (Pubitemid 46630637)
16. J.L. Barlow, L.F. Drynan, and D.R. Hewett A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q-syndrome Nat Med 16 2009 59 66
17. A.G. Knudson Jr Mutation and cancer: statistical study of retinoblastoma Proc Natl Acad Sci U S A 68 1971 820 823
18. B.L. Ebert, J. Pretz, and J. Bosco Identification of RPS14 as a 5q-syndrome gene by RNA interference screen Nature 451 2008 335 339
19. J. Boultwood, A. Pellagatti, and H. Cattan Gene expression profiling of CD34+ cells in patients with the 5q-syndrome Br J Haematol 139 2007 578 589 (Pubitemid 350043812)
20. E.N. Oliva, M. Cuzzola, and F. Nobile Changes in RPS14 expression levels during lenalidomide treatment in Low- and Intermediate-1-risk myelodysplastic syndromes with chromosome 5q deletion Eur J Haematol 85 2010 231 235
21. A. Valencia, J. Cervera, E. Such, M.A. Sanz, and G.F. Sanz Lack of RPS14 promoter aberrant methylation supports the haploinsufficiency model for the 5q-syndrome Blood 112 2008 918
22. N. Draptchinskaia, P. Gustavsson, and B. Andersson The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia Nat Genet 21 1999 169 175 (Pubitemid 29070361)
23. A. Narla, and B.L. Ebert Ribosomopathies: human disorders of ribosome dysfunction Blood 115 2010 3196 3205
24. V. Choesmel, S. Fribourg, and A.H. Aguissa-Toure Mutation of ribosomal protein RPS24 in Diamond-Blackfan anemia results in a ribosome biogenesis disorder Hum Mol Genet 17 2008 1253 1263 (Pubitemid 351566962)
25. R. Cmejla, J. Cmejlova, H. Handrkova, J. Petrak, and D. Pospisilova Ribosomal protein S17 gene (RPS17) is mutated in Diamond-Blackfan anemia Hum Mutat 28 2007 1178 1182 (Pubitemid 350250381)
26. J.E. Farrar, M. Nater, and E. Caywood Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia Blood 112 2008 1582 1592
27. H.T. Gazda, A. Grabowska, and L.B. Merida-Long Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia Am J Hum Genet 79 2006 1110 1118 (Pubitemid 44868071)
28. A. Pellagatti, T. Marafioti, and J.C. Paterson Induction of p53 and up-regulation of the p53 pathway in the human 5q-syndrome Blood 115 2010 2721 2723
29. K.A. McGowan, J.Z. Li, and C.Y. Park Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects Nat Genet 40 2008 963 970
30. S. Dutt, A. Narla, and K. Lin Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells Blood 117 2011 2567 2576
31. M.S. Kumar, A. Narla, and A. Nonami Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q-syndrome Blood 114 2009 abstract 947
32. D.T. Starczynowski, F. Kuchenbauer, and B. Argiropoulos Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype Nat Med 16 2010 49 58
33. L. Nilsson, I. Astrand-Grundstrom, and I. Arvidsson Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level Blood 96 2000 2012 2021
34. L. Nilsson, P. Eden, and E. Olsson The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes Blood 110 2007 3005 3014 (Pubitemid 350006955)
35. I.M. Min, G. Pietramaggiori, F.S. Kim, E. Passegue, K.E. Stevenson, and A.J. Wagers The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells Cell Stem Cell 2 2008 380 391 (Pubitemid 351455239)
36. J.M. Joslin, A.A. Fernald, and T.R. Tennant Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders Blood 110 2007 719 726 (Pubitemid 47105411)
37. J. Wang, A.A. Fernald, J. Anastasi, M.M. Le Beau, and Z. Qian Haploinsufficiency of Apc leads to ineffective hematopoiesis Blood 115 2010 3481 3488
38. S.W. Lane, S.M. Sykes, and F. Al-Shahrour The Apc(min) mouse has altered hematopoietic stem cell function and provides a model for MPD/MDS Blood 115 2010 3489 3497
39. S. Lehmann, J. O'Kelly, S. Raynaud, S.E. Funk, E.H. Sage, and H.P. Koeffler Common deleted genes in the 5q-syndrome: thrombocytopenia and reduced erythroid colony formation in SPARC null mice Leukemia 21 2007 1931 1936 (Pubitemid 47299966)
40. A. Pellagatti, M. Jadersten, and A.M. Forsblom Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q-syndrome patients Proc Natl Acad Sci U S A 104 2007 11406 11411 (Pubitemid 47175153)
41. K.M. Eisenmann, K.J. Dykema, and S.F. Matheson 5q- myelodysplastic syndromes: chromosome 5q genes direct a tumor-suppression network sensing actin dynamics Oncogene 28 2009 3429 3441
42. M.M. Patnaik, T.L. Lasho, and C.M. Finke WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutations Leukemia 24 2010 1283 1289
43. D. Haase, U. Germing, and J. Schanz New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients Blood 110 2007 4385 4395 (Pubitemid 351377805)
44. S. Grisendi, R. Bernardi, and M. Rossi Role of nucleophosmin in embryonic development and tumorigenesis Nature 437 2005 147 153 (Pubitemid 41613442)
45. L.M. Calvi, G.B. Adams, and K.W. Weibrecht Osteoblastic cells regulate the haematopoietic stem cell niche Nature 425 2003 841 846 (Pubitemid 37351468)
46. D.T. Scadden The stem-cell niche as an entity of action Nature 441 2006 1075 1079 (Pubitemid 43990719)
47. M.H. Raaijmakers, S. Mukherjee, and S. Guo Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia Nature 464 2010 852 857
48. J.L. Barlow, L.F. Drynan, and D.R. Hewett A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q-syndrome Nat Med 16 2010 59 66